-
EP1443901
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1443901
| EP1443901 - SOLUBLE DRUG EXTENDED RELEASE SYSTEM [Right-click to bookmark this link] | Status | The application has been refused Status updated on 12.04.2013 Database last updated on 06.07.2024 | Most recent event Tooltip | 12.04.2013 | Refusal of application | published on 15.05.2013 [2013/20] | Applicant(s) | For all designated states Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP | [2011/25] |
| Former [2010/41] | For all designated states Astellas Pharma Technologies, Inc. 1050 Arastradero Road Palo Alto, CA 94303 / US | ||
| For all designated states Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP | |||
| Former [2004/33] | For all designated states Yamanouchi Pharma Technologies, Inc. 1050 Arastradero Road, Stanford Research Park Palo Alto, CA 94303 / US | ||
| For all designated states YAMANOUCHI PHARMACEUTICAL CO. LTD. No. 3-11 Nihonbashi-Honcho, 2-chome Chuo-ku Tokyo 103-8411 / JP | Inventor(s) | 01 /
ROGERS, Victoria 3090 Longview Drive San Bruno, CA 94066 / US | 02 /
DOR, Philippe, J., M. 22525 Balboa Road Cupertino, CA 95014-5454 / US | 03 /
FIX, Joseph, A. 722 Columbus Street Half Moon Bay, CA 94019 / US | 04 /
KOJIMA, Hiroyuki 3-8-25-205 Yaizu Yaizu, Shizuoka 425-0026 / JP | 05 /
SAKO, Kazuhiro 4-7-7 Higashikogawa Yaizu, Shizuoka 425-0035 / JP | [2004/33] | Representative(s) | Brasnett, Adrian Hugh, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2004/33] | Brasnett, Adrian Hugh, et al Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 02782303.8 | 12.11.2002 | [2004/33] | WO2002US36681 | Priority number, date | US20010007877 | 13.11.2001 Original published format: US 7877 | [2004/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03041656 | Date: | 22.05.2003 | Language: | EN | [2003/21] | Type: | A2 Application without search report | No.: | EP1443901 | Date: | 11.08.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.05.2003 takes the place of the publication of the European patent application. | [2004/33] | Search report(s) | International search report - published on: | US | 23.10.2003 | (Supplementary) European search report - dispatched on: | EP | 20.05.2010 | Classification | IPC: | A61K9/00, A61K9/127, A61K9/52, A61K9/22, A61K9/14, A61K31/78 | [2004/33] | CPC: |
A61K9/2013 (EP);
A61K9/20 (KR);
A61K9/00 (KR);
A61K9/2018 (EP);
A61K9/2027 (EP);
A61K9/2031 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/33] | Extension states | AL | 12.05.2004 | LT | 12.05.2004 | LV | 12.05.2004 | MK | 12.05.2004 | RO | 12.05.2004 | SI | 12.05.2004 | Title | German: | SYSTEM FÜR DIE VERZÖGERTE FREISETZUNG VON LÖSLICHEN MEDIKAMENTEN | [2004/33] | English: | SOLUBLE DRUG EXTENDED RELEASE SYSTEM | [2004/33] | French: | SYSTEME DE LIBERATION PROLONGEE DE MEDICAMENTS SOLUBLES | [2004/33] | Entry into regional phase | 12.05.2004 | National basic fee paid | 12.05.2004 | Search fee paid | 12.05.2004 | Designation fee(s) paid | 12.05.2004 | Examination fee paid | Examination procedure | 28.04.2003 | Request for preliminary examination filed International Preliminary Examining Authority: US | 12.05.2004 | Amendment by applicant (claims and/or description) | 12.05.2004 | Examination requested [2004/33] | 18.10.2010 | Despatch of a communication from the examining division (Time limit: M06) | 08.03.2011 | Reply to a communication from the examining division | 27.11.2012 | Application refused, date of legal effect [2013/20] | 27.11.2012 | Date of oral proceedings | 12.12.2012 | Despatch of communication that the application is refused, reason: substantive examination [2013/20] | 12.12.2012 | Minutes of oral proceedings despatched | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.10.2010 | Fees paid | Renewal fee | 22.11.2004 | Renewal fee patent year 03 | 29.11.2005 | Renewal fee patent year 04 | 27.11.2006 | Renewal fee patent year 05 | 27.11.2007 | Renewal fee patent year 06 | 07.11.2008 | Renewal fee patent year 07 | 06.11.2009 | Renewal fee patent year 08 | 22.11.2010 | Renewal fee patent year 09 | 14.11.2011 | Renewal fee patent year 10 | 13.11.2012 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]GB1263392 (AMERICAN HOME PROD [US]) [X] 1-32 * page 1, line 11 - line 23 * * examples 5,6 ** claim - *; | [X]WO9706787 (DYER ALISON MARGARET [ZA], et al) [X] 1-32 * page 5, paragraph l * * examples 2,21; table 2 * * claim - *; | [X]WO0015198 (RANBAXY LAB LTD [IN], et al) [X] 1-32 * page 6, line 18 - page 7, line 19 * * example - * * claim - *; | [X] - TOLIAT T ET AL, "Controlled release (CR) tablet formulation of diltiazem HCL using different polymers as retardant substances", PHARMACEUTICAL RESEARCH (NEW YORK), & ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS; BOSTON, MASSACHUSETTS, USA; NOVEMBER 2-6, 1997, (199711), vol. 14, no. 11 SUPPL., ISSN 0724-8741, page S598, XP008121997 [X] 1-32 * abstract * | [X] - KRISTMUNDSDOTTIR T ET AL, "CHITOSAN MATRIX TABLETS: THE INFLUENCE OF EXCIPIENTS ON DRUG RELEASE", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, NEW YORK, NY, US LNKD- DOI:10.3109/03639049509069249, (19950101), vol. 21, no. 13, ISSN 0363-9045, pages 1591 - 1598, XP009026687 [X] 1-32 * abstract * * page 1595, paragraph 4 * DOI: http://dx.doi.org/10.3109/03639049509069249 | International search | [X]US5219563 (DOUGLAS STEPHEN J [GB], et al); | [Y]US5788959 (SINGH MANISH [US]) | Examination | EP0661045 | - MAGGI L ET AL, "Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, (20020215), vol. 23, no. 4, doi:10.1016/S0142-9612(01)00223-X, ISSN 0142-9612, pages 1113 - 1119, XP004348129 DOI: http://dx.doi.org/10.1016/S0142-9612(01)00223-X | - ATTWOOD D ET AL, "AGGREGATION OF ANTI DEPRESSANT DRUGS IN AQUEOUS SOLUTION", JOURNAL OF PHARMACY AND PHARMACOLOGY, LONDON; GB, (19780101), vol. 30, no. 3, ISSN 0022-3573, pages 176 - 180, XP008122056 |